-
Keros Therapeutics (NASDAQ:KROS) Shares Down 2.7% Following Analyst Downgrade
Source: Buzz FX / 24 Dec 2024 11:01:12 America/Chicago
Keros Therapeutics (NASDAQ:KROS) Shares Down 2.7% Following Analyst Downgrade Written by MarketBeat December 24, 2024 Share Link copied to clipboard. Keros Therapeutics, Inc. ( NASDAQ:KROS - Get Free Report ) shares dropped 2.7% on Tuesday
Read more...